{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:50:08Z","timestamp":1788587408032,"version":"build-2803163510"},"reference-count":23,"publisher":"Japanese Society of Internal Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,4,1]]},"DOI":"10.2169\/internalmedicine.1462-18","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T17:31:29Z","timestamp":1545067889000},"page":"921-927","source":"Crossref","is-referenced-by-count":23,"title":["A High PD-L1 Expression in Pulmonary Pleomorphic Carcinoma Correlates with Parietal-pleural Invasion and Might Predict a Poor Prognosis"],"prefix":"10.2169","volume":"58","author":[{"given":"Maiko","family":"Naito","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, National Hospital Organization Kinki-chuo Chest Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Tamiya","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Hospital Organization Kinki-chuo Chest Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Clinical Research Center, National Hospital Organization Kinki-chuo Chest Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Hospital Organization Kinki-chuo Chest Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Saijo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Hospital Organization Kinki-chuo Chest Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Naoki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Hospital Organization Kinki-chuo Chest Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoichi","family":"Okishio","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, National Hospital Organization Kinki-chuo Chest Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyungeun","family":"Yoon","sequence":"additional","affiliation":[{"name":"Department of Surgery, National Hospital Organization Kinki-chuo Chest Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Kasai","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Clinical Research Center, National Hospital Organization Kinki-chuo Chest Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihide","family":"Matsumura","sequence":"additional","affiliation":[{"name":"Department of Surgery, National Hospital Organization Kinki-chuo Chest Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Atagi","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, National Hospital Organization Kinki-chuo Chest Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Fishback NF, Travis WD, Moran CA, Guinee DG Jr, McCarthy WF, Koss MN. Pleomorphic (spindle\/giant cell) carcinoma of the lung. A clinicopathologic correlation of 78 cases. Cancer 73: 2936-2945, 1994.","DOI":"10.1002\/1097-0142(19940615)73:12<2936::AID-CNCR2820731210>3.0.CO;2-U"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Travis WD. Pathology of lung cancer. Clin Chest Med 23: 65-81, 2002.","DOI":"10.1016\/S0272-5231(03)00061-3"},{"key":"3","unstructured":"3. Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. International Agency for Research on Cancer, Lyon, 2015."},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Chang YL, Lee YC, Shih JY, Wu CT. Pulmonary pleomorphic (spindle) cell carcinoma: peculiar clinicopathologic manifestations different from ordinary non-small cell carcinoma. Lung Cancer 34: 91-97, 2001.","DOI":"10.1016\/S0169-5002(01)00224-0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Raveglia F, Mezzetti M, Panigalli T, et al. Personal experience in surgical management of pulmonary pleomorphic carcinoma. Ann Thorac Surg 78: 1742-1747, 2004.","DOI":"10.1016\/j.athoracsur.2004.04.084"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Bae HM, Min HS, Lee SH, et al. Palliative chemotherapy for pulmonary pleomorphic carcinoma. Lung Cancer 58: 112-115, 2007.","DOI":"10.1016\/j.lungcan.2007.05.006"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Chang YL, Yang CY, Lin MW, Wu CT, Yang PC. High co-expression of PD-L1 and HIF-1alpha correlates with tumour necrosis in pulmonary pleomorphic carcinoma. Eur J Cancer 60: 125-135, 2016.","DOI":"10.1016\/j.ejca.2016.03.012"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Yvorel V, Patoir A, Casteillo F, et al. PD-L1 expression in pleomorphic, spindle cell and giant cell carcinoma of the lung is related to TTF-1, p40 expression and might indicate a worse prognosis. PLoS One 12: e0180346, 2017.","DOI":"10.1371\/journal.pone.0180346"},{"key":"9","unstructured":"9. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 7th ed. Springer, New York, 2010."},{"key":"10","unstructured":"10. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45: 228-247, 2009."},{"key":"11","unstructured":"11. Kim S, Kim MY, Koh J, et al. Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: comparison of sarcomatous and carcinomatous areas. Eur J Cancer 51: 2698-2707, 2015."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Vieira T, Antoine M, Hamard C, et al. Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages. Lung Cancer 98: 51-58, 2-16.","DOI":"10.1016\/j.lungcan.2016.05.013"},{"key":"13","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.lungcan.2014.06.004","volume":"85","author":"T Vieira","year":"2014","unstructured":"13. Vieira T, Antoine M, Ruppert AM, et al. Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung. Lung Cancer 85: 276-281, 2014.","journal-title":"Lung Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/0169-5002","issn-type":"print"},{"key":"14","unstructured":"14. Pan ZK, Ye F, Wu X, An HX, Wu JX. Clinicopathological and prognostic significance of programmed cell death ligand1 (PD-L1) expression in patients with non-small cell lung cancer: a meta-analysis. J Thorac Dis 7: 462-470, 2015."},{"key":"15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.lungcan.2015.05.007","volume":"89","author":"WA Cooper","year":"2015","unstructured":"15. Cooper WA, Tran T, Vilain RE, et al. PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma. Lung Cancer 89: 181-188, 2015.","journal-title":"Lung Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/0169-5002","issn-type":"print"},{"key":"16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.lungcan.2016.04.021","volume":"98","author":"M Shimoji","year":"2016","unstructured":"16. Shimoji M, Shimizu S, Sato K, et al. Clinical and pathologic features of lung cancer expressing programmed cell death ligand 1 (PD-L1). Lung Cancer 98: 9-75, 2016.","journal-title":"Lung Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/0169-5002","issn-type":"print"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Zhang M, Wang D, Sun Q, et al. Prognostic significance of PD-L1 expression and <sup>18<\/sup>F-FDG PET\/CT in surgical pulmonary squamous cell carcinoma. Oncotarget 8: 51630-51640, 2017.","DOI":"10.18632\/oncotarget.18257"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Francisco LM, Sage PT, Sharpe AH. The PD-1 pathway in tolerance and autoimmunity. Immunol Rev 236: 219-242, 2010.","DOI":"10.1111\/j.1600-065X.2010.00923.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12: 252-264, 2012.","DOI":"10.1038\/nrc3239"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Iwai Y, Ishida M, Tanaka Y, Okazaki T, Honjo T, Minato N. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc Natl Acad Sci USA 99: 12293-12297, 2002.","DOI":"10.1073\/pnas.192461099"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Freeman GJ, Long AJ, Iwai Y, et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192: 1027-1034, 2000.","DOI":"10.1084\/jem.192.7.1027"},{"key":"22","unstructured":"22. Reck M, Rodr\u00edguez-Abreu D, Robinson AG, et al. KEYNOTE-024 investigators: pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N Engl J Med 375: 1823-1833, 2016."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kanazu M, Uenami T, Yano Y, et al. Case series of pleomorphic carcinomas of the lung treated with nivolumab. Thorac Cancer 8: 724-728, 2017.","DOI":"10.1111\/1759-7714.12505"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/7\/58_1462-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:16:29Z","timestamp":1559348189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/7\/58_1462-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,1]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1462-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,1]]}}}